These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 7198620

  • 1. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V, Bharadwaj VP, Venkatesan K, Girdhar BK.
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [Abstract] [Full Text] [Related]

  • 2. Vitamin E and dapsone-induced hemolysis.
    Kelly JW, Scott J, Sandland M, Van der Weyden MB, Marks R.
    Arch Dermatol; 1984 Dec; 120(12):1582-4. PubMed ID: 6508329
    [Abstract] [Full Text] [Related]

  • 3. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P, Guerra P, Nasser S, Simon M.
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [Abstract] [Full Text] [Related]

  • 4. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S, Karthikeyan S, Ramu G.
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [Abstract] [Full Text] [Related]

  • 5. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S, Rege VL, Sehgal VN.
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [Abstract] [Full Text] [Related]

  • 6. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN, Gupta SC, Bajaj AK, Srivastava NP, Mehrotra TN.
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [Abstract] [Full Text] [Related]

  • 7. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM, Díaz NB, Artaza JR, Carbia CD, Nazer R, Valdez R.
    Medicina (B Aires); 1997 Dec; 57(2):150-4. PubMed ID: 9532824
    [Abstract] [Full Text] [Related]

  • 8. Lactate dehydrogenase isoenzymes in leprosy patients on multi drug therapy--a preliminary report.
    Dhandayuthapani S, Bhatia VN.
    Indian J Lepr; 1988 Apr; 60(2):196-201. PubMed ID: 3192968
    [Abstract] [Full Text] [Related]

  • 9. Serum enzyme profile in tuberculoid leprosy.
    Bulakh PM, Kowale CN, Ranade SM, Deshpande VA.
    Lepr India; 1982 Jan; 54(1):69-74. PubMed ID: 7098444
    [Abstract] [Full Text] [Related]

  • 10. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
    Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D.
    Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
    [Abstract] [Full Text] [Related]

  • 11. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):318-27. PubMed ID: 12035293
    [Abstract] [Full Text] [Related]

  • 12. Effect of dapsone on haemoglobin concentration in patients with leprosy.
    Byrd SR, Gelber RH.
    Lepr Rev; 1991 Jun; 62(2):171-8. PubMed ID: 1870379
    [Abstract] [Full Text] [Related]

  • 13. Hematological alterations in lepromatous leprosy: A cross-sectional observational study.
    Gupta B, Gupta S, Chaudhary M, Raj AT, Awan KH, Patil S.
    Dis Mon; 2020 Jul; 66(7):100919. PubMed ID: 31796205
    [Abstract] [Full Text] [Related]

  • 14. Haemolytic effects of DDS in leprosy patients.
    Khaire DS, Magar NG.
    Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
    [No Abstract] [Full Text] [Related]

  • 15. Hemolysis parameters of St. Jude Medical: Hemodynamic Plus and Regent valves in aortic position.
    Suedkamp M, Lercher AJ, Mueller-Riemenschneider F, LaRosee K, Tossios P, Mehlhorn U.
    Int J Cardiol; 2004 May; 95(1):89-93. PubMed ID: 15159044
    [Abstract] [Full Text] [Related]

  • 16. Serum lysozyme in leprosy.
    Naik SS, Gurnani S.
    Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
    [Abstract] [Full Text] [Related]

  • 17. Biochemical alterations in the serum of armadillos (Dasypus novemcinctus) infected with Mycobacterium leprae. A preliminary report.
    Rojas-Espinosa O, Quesada-Pascual F, Oltra A, Arce P, Estrada-Parra S, Buchanan TM.
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):262-8. PubMed ID: 4020215
    [Abstract] [Full Text] [Related]

  • 18. Prothionamide and dapsone therapy in leprosy--a clinical study.
    Kundu SK, Hazra SK, Chaudhury SK, Chatterjee B.
    Indian J Lepr; 1985 Jun; 57(1):90-6. PubMed ID: 3839829
    [Abstract] [Full Text] [Related]

  • 19. A study of blood ascorbic acid in leprosy.
    Sinha SN, Gupta SC, Bajaj AK, Singh PA, Kumar P.
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):159-62. PubMed ID: 6539308
    [Abstract] [Full Text] [Related]

  • 20. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z, Zhang R, Zhou D, Chen J.
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.